The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation
Open accessAbstract
Despite lipid nanoparticles' (LNPs) success in the effective and safe delivery of mRNA vaccines, an inhalation-based mRNA therapy for lung diseases remains challenging. LNPs tend to disintegrate due to shear stress during aerosolization, leading to ineffective delivery. Therefore, LNPs need to remain stable through the process of nebulization and mucus penetration, yet labile enough for endosomal escape. To meet these opposing needs, we utilized PEG lipid to enhance the surficial stability of LNPs with the inclusion of a cholesterol analog, β-sitosterol, to improve endosomal escape. Increased PEG concentrations in LNPs enhanced the shear resistance and mucus penetration, while β-sitosterol provided LNPs with a polyhedral shape, facilitating endosomal escape. The optimized LNPs exhibited a uniform particle distribution, a polyhedral morphology, and a rapid mucosal diffusion with enhanced gene transfection. Inhaled LNPs led to localized protein production in the mouse lung without pulmonary or systemic toxicity. Repeated administration of these LNPs led to sustained protein production in the lungs. Lastly, mRNA encoding the cystic fibrosis transmembrane conductance regulator (CFTR) was delivered after nebulization to a CFTR-deficient animal model, resulting in the pulmonary expression of this therapeutic protein. This study demonstrated the rational design approach for clinical translation of inhalable LNP-based mRNA therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Cheng, Q., Wei, T., Farbiak, L., Johnson, L. T., Dilliard, S. A., & Siegwart, D. J. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0669-6 · Cited by 2,383
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., Seitzer, J., O’Connell, D., Walsh, K. R., Wood, K., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107454 · Cited by 1,801
Airway Mucus Function and Dysfunction
Fahy, J. V., & Dickey, B. F. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0910061 · Cited by 1,722
O'Sullivan, B. P., & Freedman, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60327-5 · Cited by 1,320
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261
On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles
Dilliard, S. A., Cheng, Q., & Siegwart, D. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109256118 · Cited by 1,018
Chemistry of Lipid Nanoparticles for RNA Delivery
Eygeris, Y., Gupta, M., Kim, J., & Sahay, G. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00544 · Cited by 873
Self-citationCationic polymers and their therapeutic potential
Samal, S. K., Dash, M., Van Vlierberghe, S., Kaplan, D. L., Chiellini, E., van Blitterswijk, C., Moroni, L., & Dubruel, P. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35094g · Cited by 714
Liu, S., Cheng, Q., Wei, T., Yu, X., Johnson, L. T., Farbiak, L., & Siegwart, D. J. (2021) · Nature Materials · doi:10.1038/s41563-020-00886-0 · Cited by 653
Perry, J. L., Reuter, K. G., Kai, M. P., Herlihy, K. P., Jones, S. W., Luft, J. C., Napier, M., Bear, J. E., & DeSimone, J. M. (2012) · Nano Letters · doi:10.1021/nl302638g · Cited by 606
Patel, S., Ashwanikumar, N., Robinson, E., Xia, Y., Mihai, C., Griffith, J. P., Hou, S., Esposito, A. A., Ketova, T., Welsher, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14527-2 · Cited by 601
Xu, Q., Ensign, L. M., Boylan, N. J., Schön, A., Gong, X., Yang, J.-C., Lamb, N. W., Cai, S., Yu, T., Freire, E., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b03876 · Cited by 568
Yanez Arteta, M., Kjellman, T., Bartesaghi, S., Wallin, S., Wu, X., Kvist, A. J., Dabkowska, A., Székely, N., Radulescu, A., Bergenholtz, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720542115 · Cited by 534
Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514
Self-citationMui, B. L., Tam, Y. K., Jayaraman, M., Ansell, S. M., Du, X., Tam, Y. Y. C., Lin, P. J., Chen, S., Narayanannair, J. K., Rajeev, K. G., et al. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2013.66 · Cited by 505
Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs
Lokugamage, M. P., Vanover, D., Beyersdorf, J., Hatit, M. Z. C., Rotolo, L., Echeverri, E. S., Peck, H. E., Ni, H., Yoon, J.-K., Kim, Y., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00786-x · Cited by 495
Progress in therapies for cystic fibrosis
De Boeck, K., & Amaral, M. D. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00023-0 · Cited by 451
Inflammatory mechanisms in the lung
Yu, J. (2008) · Journal of Inflammation Research · doi:10.2147/jir.s4385 · Cited by 443
Measuring the lung function in the mouse: the challenge of size
Irvin, C. G., & Bates, J. H. (2003) · Respiratory Research · doi:10.1186/rr199 · Cited by 407
How cholesterol stiffens unsaturated lipid membranes
Chakraborty, S., Doktorova, M., Molugu, T. R., Heberle, F. A., Scott, H. L., Dzikovski, B., Nagao, M., Stingaciu, L.-R., Standaert, R. F., Barrera, F. N., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004807117 · Cited by 397
Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium
Patel, A. K., Kaczmarek, J. C., Bose, S., Kauffman, K. J., Mir, F., Heartlein, M. W., DeRosa, F., Langer, R., & Anderson, D. G. (2019) · Advanced Materials · doi:10.1002/adma.201805116 · Cited by 381
Deconvoluting Lipid Nanoparticle Structure for Messenger RNA Delivery
Eygeris, Y., Patel, S., Jozic, A., & Sahay, G. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c01386 · Cited by 379
Self-citationInfluence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
Chen, S., Tam, Y. Y. C., Lin, P. J. C., Sung, M. M. H., Tam, Y. K., & Cullis, P. R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.059 · Cited by 366
The Clinical Chemistry of Laboratory Animals
Kurtz, D. M., & Travlos, G. S. (2017) · CRC Press eBooks · doi:10.1201/9781315155807 · Cited by 300
Karikó, K., Muramatsu, H., Keller, J. M., & Weissman, D. (2012) · Molecular Therapy · doi:10.1038/mt.2012.7 · Cited by 282
Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
Robinson, E., MacDonald, K. D., Slaughter, K., McKinney, M., Patel, S., Sun, C., & Sahay, G. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.014 · Cited by 272
Self-citationPaunovska, K., Da Silva Sanchez, A. J., Sago, C. D., Gan, Z., Lokugamage, M. P., Islam, F. Z., Kalathoor, S., Krupczak, B. R., & Dahlman, J. E. (2019) · Advanced Materials · doi:10.1002/adma.201807748 · Cited by 205
Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs
Ehre, C., Worthington, E. N., Liesman, R. M., Grubb, B. R., Barbier, D., O’Neal, W. K., Sallenave, J.-M., Pickles, R. J., & Boucher, R. C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206552109 · Cited by 195
Emerging inhalation aerosol devices and strategies: Where are we headed?
Zhou, Q. (., Tang, P., Leung, S. S. Y., Chan, J. G. Y., & Chan, H.-K. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.006 · Cited by 188
Systemic messenger RNA as an etiological treatment for acute intermittent porphyria
Jiang, L., Berraondo, P., Jericó, D., Guey, L. T., Sampedro, A., Frassetto, A., Benenato, K. E., Burke, K., Santamaría, E., Alegre, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0199-z · Cited by 181
Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery
Herrera, M., Kim, J., Eygeris, Y., Jozic, A., & Sahay, G. (2021) · Biomaterials Science · doi:10.1039/d0bm01947j · Cited by 167
Self-citationAerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments
Zhang, H., Leal, J., Soto, M. R., Smyth, H. D. C., & Ghosh, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111042 · Cited by 165
Immune Modulation by Human Secreted RNases at the Extracellular Space
Lu, L., Li, J., Moussaoui, M., & Boix, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01012 · Cited by 160
Yao, X., Gordon, E. M., Figueroa, D. M., Barochia, A. V., & Levine, S. J. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0060tr · Cited by 138
Myerson, J. W., Patel, P., Rubey, K. M., Zamora, M. E., Zaleski, M. H., Habibi, N., Walsh, L. R., Lee, Y.-W., Luther, D. C., Ferguson, L. T., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00997-y · Cited by 129
Airway disease phenotypes in animal models of cystic fibrosis
McCarron, A., Donnelley, M., & Parsons, D. (2018) · Respiratory Research · doi:10.1186/s12931-018-0750-y · Cited by 91
Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution
Cui, H., Jiang, D., Banerjee, S., Xie, N., Kulkarni, T., Liu, R.-M., Duncan, S. R., & Liu, G. (2020) · JCI Insight · doi:10.1172/jci.insight.134539 · Cited by 81
Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis
Haque, A. K. M. A., Dewerth, A., Antony, J. S., Riethmüller, J., Schweizer, G. R., Weinmann, P., Latifi, N., Yasar, H., Pedemonte, N., Sondo, E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34960-0 · Cited by 80
Suzuki, S., Crane, A. M., Anirudhan, V., Barillá, C., Matthias, N., Randell, S. H., Rab, A., Sorscher, E. J., Kerschner, J. L., Yin, S., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.04.021 · Cited by 78
Pulmonary monoclonal antibody delivery via a portable microfluidic nebulization platform
Cortez‐Jugo, C., Qi, A., Rajapaksa, A. E., Friend, J. R., & Yeo, L. Y. (2015) · Biomicrofluidics · doi:10.1063/1.4917181 · Cited by 76
Nonhuman Primate Models of Respiratory Disease: Past, Present, and Future
Miller, L. A., Royer, C. M., Pinkerton, K. E., & Schelegle, E. S. (2017) · ILAR Journal · doi:10.1093/ilar/ilx030 · Cited by 74
Naturally Derived Membrane Lipids Impact Nanoparticle-Based Messenger RNA Delivery
Kim, J., Jozic, A., & Sahay, G. (2020) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-020-00619-y · Cited by 61
Self-citationRobust real-time 3D single-particle tracking using a dynamically moving laser spot
Hou, S., Lang, X., & Welsher, K. (2017) · Optics Letters · doi:10.1364/ol.42.002390 · Cited by 51
Self-citationNanomedicine hitchhikes on neutrophils to the inflamed lung
Kim, J., & Sahay, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00981-6 · Cited by 37
Self-citationMukherjee, A., MacDonald, K. D., Kim, J., Henderson, M. I., Eygeris, Y., & Sahay, G. (2020) · Science Advances · doi:10.1126/sciadv.abc5911 · Cited by 25
Self-citationNebulizer therapy in cystic fibrosis: An overview
Collins, N. (2009) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2009.s19003 · Cited by 22
Metadata
- Authors
- Kim, J., Jozic, A., Lin, Y., Eygeris, Y., Bloom, E., Tan, X., Acosta, C., MacDonald, K. D., Welsher, K. D., & Sahay, G.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2022-08-29
- Volume
- 16
- Issue
- 9
- Pages
- 14792-14806
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W4293510452
- Cited by
- 273
- References
- 48
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.